Lv22
120 积分 2025-07-31 加入
Anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy bb21217 for relapsed and refractory multiple myeloma: results from the phase 1 CRB-402 study
7天前
已关闭
OA-47 Additional analysis of CARTITUDE-4: Cilta-cel vs standard of care (PVd or DPd) in lenalidomide-refractory patients with multiple myeloma and 1–3 prior lines of therapy
7天前
已关闭
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
18天前
已完结
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
18天前
已完结
Investigation of mRNA Cell Therapy as a Treatment for Autoimmune Disease in Patients with Myastenia Gravis
18天前
已关闭
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
18天前
已完结
Characterization of B cell reset following B cell depleting therapies
18天前
已完结
CD19/BCMA CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus - Safety and Preliminary Efficacy Data from a Phase I Clinical Study
19天前
已完结
Poster sessions
20天前
已完结
皖公网安备34019202002308
